ICU Medical (NASDAQ:ICUI) COO Christian Voigtlander Sells 8,929 Shares

ICU Medical, Inc. (NASDAQ:ICUI) COO Christian Voigtlander sold 8,929 shares of the firm’s stock in a transaction on Tuesday, August 11th. The shares were sold at an average price of $182.93, for a total transaction of $1,633,381.97. Following the completion of the sale, the chief operating officer owned 37,377 shares in the company, valued at $6,837,374.61. The trade was a 19.28% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this hyperlink.

ICU Medical Stock Down 0.2%

ICU Medical stock opened at $182.08 on Wednesday. The stock has a market cap of $4.55 billion, a PE ratio of 154.31, a P/E/G ratio of 2.55 and a beta of 0.74. The company has a debt-to-equity ratio of 0.56, a current ratio of 2.43 and a quick ratio of 1.21. The stock’s fifty day moving average is $153.69 and its two-hundred day moving average is $141.31. ICU Medical, Inc. has a 1-year low of $107.50 and a 1-year high of $192.85.

ICU Medical (NASDAQ:ICUI) last released its quarterly earnings data on Thursday, August 6th. The medical instruments supplier reported $2.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.91 by $0.46. The business had revenue of $547.88 million during the quarter, compared to analysts’ expectations of $533.44 million. ICU Medical had a return on equity of 7.91% and a net margin of 1.39%.The business’s quarterly revenue was up .5% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.10 EPS. ICU Medical has set its FY 2026 guidance at 8.600-9.000 EPS. On average, sell-side analysts expect that ICU Medical, Inc. will post 6.51 EPS for the current fiscal year.

Institutional Trading of ICU Medical

A number of institutional investors have recently added to or reduced their stakes in the stock. Allworth Financial LP purchased a new position in ICU Medical in the second quarter valued at about $26,000. Hilton Head Capital Partners LLC purchased a new stake in shares of ICU Medical during the 4th quarter worth approximately $32,000. Covestor Ltd grew its holdings in shares of ICU Medical by 22.1% in the 4th quarter. Covestor Ltd now owns 696 shares of the medical instruments supplier’s stock worth $99,000 after acquiring an additional 126 shares during the period. Strs Ohio grew its holdings in shares of ICU Medical by 60.0% in the 4th quarter. Strs Ohio now owns 800 shares of the medical instruments supplier’s stock worth $114,000 after acquiring an additional 300 shares during the period. Finally, Rockefeller Capital Management L.P. increased its stake in ICU Medical by 21.6% in the 4th quarter. Rockefeller Capital Management L.P. now owns 823 shares of the medical instruments supplier’s stock valued at $117,000 after purchasing an additional 146 shares in the last quarter. Hedge funds and other institutional investors own 96.10% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts recently commented on ICUI shares. Needham & Company LLC upped their price target on shares of ICU Medical from $165.00 to $187.00 and gave the company a “buy” rating in a research report on Friday, August 7th. Sanford C. Bernstein downgraded shares of ICU Medical to a “market perform” rating in a research report on Monday, June 15th. Zacks Research lowered shares of ICU Medical from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, July 28th. Jefferies Financial Group raised shares of ICU Medical to a “strong-buy” rating in a report on Thursday, May 7th. Finally, Piper Sandler increased their target price on shares of ICU Medical from $163.00 to $195.00 and gave the stock an “overweight” rating in a research note on Friday, August 7th. Two equities research analysts have rated the stock with a Strong Buy rating, four have given a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $192.80.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.